Monday, 22 April 2024
Research
Our webinar for potential applicants of the Advancing Treatment Award is now available for you to watch!
The webinar provided information and tips on how to develop a successful application. We heard from Ang Armstrong, affected by MND, Jessica Lee, our Director of Research, Dr Richard Mead and Dr Jill Richardson, respectively Chair and Vice-Chair of the MN5DF Research Review Committee (RRC). They shared their perspectives and insights with the community.
Our Chair and Vice-Chair of the RRC discussed the critical aspects of validating therapeutic targets in MND research. They emphasised the importance of using robust and relevant models and the need for a clear demonstration of target engagement and pathway modulation. Ang Armstrong emphasised the need for accessible lay summaries to ensure that research proposals are understandable to those without a scientific background, which impacts funding decisions.
Our budget for the Advancing Treatments Award 2024 is £1.75 million, we invite researchers not to miss this opportunity and submit their applications before midday on the 17th of May.
By subscribing, you confirm that you agree with our terms and conditions.